Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2019

01-01-2019 | Multicenter Seminars: IBD (MUSE: IBD)

How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease

Authors: Sara M. Lewin, Kwun Wah Wen, Fernando S. Velayos, Uma Mahadevan, Kendall R. Beck

Published in: Digestive Diseases and Sciences | Issue 1/2019

Login to get access

Excerpt

A 57-year-old man with history of Crohn’s colitis was referred for a second opinion regarding management of high-grade dysplasia found on colonoscopy. …
Literature
2.
go back to reference Participants in the Paris Workshop. The Paris classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc. 2003;58:S3–S43.CrossRef Participants in the Paris Workshop. The Paris classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc. 2003;58:S3–S43.CrossRef
4.
go back to reference Thomas T, Abrams KA, Robinson RJ, et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25:657–668.CrossRefPubMed Thomas T, Abrams KA, Robinson RJ, et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25:657–668.CrossRefPubMed
6.
go back to reference Sanduleanu S, Kaltenbach T, Barkun A, et al. Roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointest Endosc. 2016;83:212–222.CrossRef Sanduleanu S, Kaltenbach T, Barkun A, et al. Roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointest Endosc. 2016;83:212–222.CrossRef
7.
go back to reference Naymagon S, Ullman TA. Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease: past, present, and future. Gastroenterol Hepatol. 2015;11:304–311. Naymagon S, Ullman TA. Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease: past, present, and future. Gastroenterol Hepatol. 2015;11:304–311.
9.
go back to reference Baars JE, Siegel CA, van’t Spijker A, Markus T, Kuipers EJ, van der Woude CJ. Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer. Dig Liver Dis. 2010;42:777–784.CrossRefPubMed Baars JE, Siegel CA, van’t Spijker A, Markus T, Kuipers EJ, van der Woude CJ. Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer. Dig Liver Dis. 2010;42:777–784.CrossRefPubMed
Metadata
Title
How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease
Authors
Sara M. Lewin
Kwun Wah Wen
Fernando S. Velayos
Uma Mahadevan
Kendall R. Beck
Publication date
01-01-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5409-5

Other articles of this Issue 1/2019

Digestive Diseases and Sciences 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.